World's Best Scientists 2026 revealed!
Marco Chilosi

Marco Chilosi

D-Index & Metrics

Medicine

D-Index
90
Citations
24205
World Ranking
12371
National Ranking
468

Overview

Marco Chilosi is affiliated with the University of Verona in Italy and primarily works in the field of Medicine. Their research focuses on Infectious Diseases, Neurology, Molecular Biology, Immunology, and Pulmonary and Respiratory Medicine. The main topics covered in their research include Long-Term Effects of COVID-19, COVID-19 Clinical Research Studies, Inflammasome and Immune Disorders, SARS-CoV-2 and COVID-19 Research, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Immune Cell Function and Interaction, and Phagocytosis and Immune Regulation.

Among the recent publications authored by Marco Chilosi are the following:

  • "Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies," 2021, Respiration
  • "Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection," 2022, European Respiratory Journal
  • "The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime," 2021, Modern Pathology
  • "Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis," 2021, Cell Death and Differentiation
  • "Unbalanced IDO1/IDO2 Endothelial Expression and Skewed Keynurenine Pathway in the Pathogenesis of COVID-19 and Post-COVID-19 Pneumonia," 2022, Biomedicines

Frequent co-authors collaborating with Marco Chilosi include Claudia Ravaglia, Sara Piciucchi, Vincenzo Bronte, Venerino Poletti, and Claudio Doglioni.

The primary publication venues for Marco Chilosi's work include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Respiration
  • European Respiratory Journal
  • Modern Pathology
  • Cell Death and Differentiation

Best Publications

  • Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis

    Marco Chilosi;Venerino Poletti;Alberto Zamò;Maurizio Lestani

  • Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia

    Luisa Granziero;Paolo Ghia;Paola Circosta;Daniela Gottardi

  • Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

    Alberto Zamo;Roberto Chiarle;Roberto Piva;Jennifer Howes

  • Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels

    Patrizia Bonadonna;Omar Perbellini;Giovanni Passalacqua;Beatrice Caruso

  • Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.

    Luisa Carbognin;Sara Pilotto;Michele Milella;Vanja Vaccaro

  • Safety and Diagnostic Yield of Transbronchial Lung Cryobiopsy in Diffuse Parenchymal Lung Diseases: A Comparative Study versus Video-Assisted Thoracoscopic Lung Biopsy and a Systematic Review of the Literature.

    Claudia Ravaglia;Martina Bonifazi;Athol U. Wells;Sara Tomassetti

  • Transbronchial Lung Cryobiopsy in the Diagnosis of Fibrotic Interstitial Lung Diseases

    Gian Luca Casoni;Sara Tomassetti;Alberto Cavazza;Thomas V. Colby

  • Heparan Sulfate Glycosaminoglycans Are Receptors Sufficient To Mediate the Initial Binding of Adenovirus Types 2 and 5

    Mariacristina Dechecchi;P Melotti;A Bonizzato;M Santacatterina

  • Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.

    Paolo Ghia;Giuliana Strola;Luisa Granziero;Massimo Geuna

  • Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure.

    Jürgen Hetzel;Fabien Maldonado;Claudia Ravaglia;Athol U. Wells

  • Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema.

    Marco Chilosi;Angelo Carloni;Andrea Rossi;Venerino Poletti

  • The impact of lung cancer on survival of idiopathic pulmonary fibrosis

    Sara Tomassetti;Christian Gurioli;Jay H. Ryu;Paul A. Decker

  • Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.

    Roberto Chiarle;Leo M. Budel;Jeffrey Skolnik;Glauco Frizzera

  • Acute exacerbation of idiopathic pulmonary fibrosis: report of a series.

    V Ambrosini;A Cancellieri;M Chilosi;M Zompatori

  • Abnormal Re-epithelialization and Lung Remodeling in Idiopathic Pulmonary Fibrosis: The Role of ΔN-p63

    Marco Chilosi;Venerino Poletti;Bruno Murer;Maurizio Lestani

  • Lung neuroendocrine tumours: Deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D

    Michele Simbolo;Andrea Mafficini;Katarzyna O Sikora;Matteo Fassan

  • CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs

    M. Barbareschi;B. Murer;T. V. Colby;Marco Chilosi

  • Involvement of the IP-10 Chemokine in Sarcoid Granulomatous Reactions

    Carlo Agostini;Marco Cassatella;Renato Zambello;Livio Trentin

  • The pathogenesis of COPD and IPF: Distinct horns of the same devil?

    Marco Chilosi;Venerino Poletti;Andrea Rossi

  • bcl-2 Expression in pleural and extrapleural solitary fibrous tumours

    Marco Chilosi;Fabio Facchetti;Angelo P. Dei Tos;Maurizio Lestani

Frequent Co-Authors

Giovanni Pizzolo
Giovanni Pizzolo University of Verona
Aldo Scarpa
Aldo Scarpa University of Verona
Guido Martignoni
Guido Martignoni University of Verona
Claudio Doglioni
Claudio Doglioni Vita-Salute San Raffaele University
Giampaolo Tortora
Giampaolo Tortora University of Verona
Giuseppe Zamboni
Giuseppe Zamboni University of Verona
Gianpietro Semenzato
Gianpietro Semenzato University of Padua
Giorgio Inghirami
Giorgio Inghirami Cornell University
Livio Trentin
Livio Trentin University of Padua
Carlo Agostini
Carlo Agostini University of Padua

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of medicine doesn’t have to follow a single path. Numerous how to evaluate healthcare administration degree programs resources highlight the importance of accreditation, curriculum quality, and available support services for aspiring leaders in healthcare management.

For nurses looking to advance, rn to bsn programs offer a flexible way to earn a bachelor's degree and open up more career opportunities, often without intensive clinical requirements.

Ambitious nursing professionals may also consider doctorate-level programs. accelerated dnp programs online allow for a faster completion time, while easiest dnp programs can be ideal for those looking for less intensive doctoral study options.

Whether your interests lie in administration, advanced nursing, or clinical leadership, there are numerous online pathways available that align with your goals and lifestyle needs.

Best Scientists Citing Marco Chilosi

Trending Scientists